Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A Phase I/II and Pharmacokinetic Study of 96-Hour Infusional Topotecan and Paclitaxel Chemotherapy for Recurrent Müllerian Tumors

A Phase I/II and Pharmacokinetic Study of 96-Hour Infusional Topotecan and Paclitaxel Chemotherapy for Recurrent Müllerian Tumors. Proc Am Soc Clin Oncol. 2000; 19(abstr 1552).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.